A small pilot study indicated that the same communications channels might be used to send messages between the brain and the peripheral immune system
in patients with multiple sclerosis.
«Our research adds evidence that tDCS, while done remotely under a supervised treatment protocol, may provide an exciting new treatment option
for patients with multiple sclerosis who can not get relief for some of their cognitive symptoms,» says lead researcher Leigh E. Charvet, PhD, associate professor of neurology and director of research at NYU Langone's Multiple Sclerosis Comprehensive Care Center.
Dr. Kanda noted that
because patients with multiple sclerosis tend to undergo numerous contrast - enhanced brain MRI scans, the hyperintensity of the DN seen in these patients may have more to do with the large cumulative gadolinium dose than the disease itself.
Dr. Clemmons has extrapolated many of his other suggestions for degenerative myelopathy (DM) from Dr. Andy Weil's recommended program for
human patients with multiple sclerosis, a human disease that appears similar in its pathologic model to degenerative myelopathy.
Cognitive behaviour therapy administered by telephone for the treatment of depressive symptoms in
patients with multiple sclerosis significantly improved adherence to treatment and clinical outcomes.13 Management and follow up care by telephone of people with depression improves outcomes at modest cost.14 w46
First author Dr Alessandro Colasanti, from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London, explained that PET imaging revealed immune activation in the hippocampus
of patients with multiple sclerosis.
British media are reporting a significant development in the use of ethical, non-embryonic stem cells to
treat patients with multiple sclerosis (MS) and, perhaps, other auto - immune diseases.
This study, «Warmer outdoor temperature is associated with task - related increased BOLD activation
in patients with multiple sclerosis,» released by Brain Imaging & Behavior corroborates the group's previous study that established that people with MS performed worse on processing speed and memory tasks during warmer outdoor temperatures versus during cooler outdoor temperatures.
Kessler Foundation researchers previously demonstrated that
patients with multiple sclerosis (MS) demonstrate worse cognition on warmer days.
With this, the working group at the MedUni Vienna has also achieved a better generalisability of the research results so far with regard to working memory and attention in
patients with multiple sclerosis.
A pilot study has shown that treatment with deep transcranial magnetic stimulation (dTMS) significantly reduces symptoms of fatigue in
patients with multiple sclerosis (MS).
«Deep brain stimulation: A new treatment approach in
patients with multiple sclerosis.»
«These are exciting findings that... could ultimately result in new therapies to prevent worsening in
patients with multiple sclerosis,» says Stephen Waxman, a neurologist at the Yale School of Medicine.
Leaky blood vessels in the brain called cerebral microbleeds are associated with an increased risk of physical and cognitive disability in
patients with multiple sclerosis (MS), according to a new study by researchers in the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo.
A new study finds that melatonin, the «sleep hormone,» could potentially help give relief to
patients with multiple sclerosis.
Patients with multiple sclerosis had better problem solving ability and response time after training with a technology called transcranial direct current stimulation (tDCS), according to a new study published February 22, 2017 in Neuromodulation: Technology at the Neural Interface.
A Vanderbilt University Medical Center - led research team has shown that magnetic resonance imaging (MRI) can detect changes in resting - state spinal cord function in
patients with multiple sclerosis (MS).
A pilot study conducted by researchers from Charité's NeuroCure Cluster of Excellence has shown that treatment with deep transcranial magnetic stimulation (dTMS) significantly reduces symptoms of fatigue in
patients with multiple sclerosis (MS).
Kessler will conduct a study of a combination therapy using dalfampridine — a drug recently approved to improve walking in
patients with multiple sclerosis — with a standardized program of locomotor training, a rehabilitative intervention that has improved walking and other functional outcomes in persons with spinal cord injuries.
Neuroscientists at Kessler Foundation have documented increased cerebral activation in
patients with multiple sclerosis (MS) following memory retraining using the modified Story Memory Technique (mSMT).
Dr. DeLuca, a well - known expert in cognitive rehabilitation research, will discuss the cognitive issues that are often under recognized in
patients with multiple sclerosis.
The research team combined two complementary brain imaging techniques to study the relationship between hippocampal immune response, functional connections, and depressive symptoms in 13
patients with multiple sclerosis and 22 healthy control subjects.
We have found this imaging method to be very useful in
patients with multiple sclerosis, and now we are able to use it in patients who have Alzheimer's disease (AD), in order to get a sense of the problems that might be developing in their brain before memory problems occur.
It is already known that
patients with multiple sclerosis have higher rates of depression than the general population and that symptoms of multiple sclerosis arise from an abnormal response of the body's immune system.
Immune response has also been linked to depression, leading researchers to think it could be a shared pathological mechanism that leads to the increased rates of depressive symptoms in
patients with multiple sclerosis.
New research by King's College London, Imperial College London and Imanova Center for Imaging Sciences, suggests that brain inflammation could lead to increased rates of depressive symptoms in
patients with multiple sclerosis.
A UC San Francisco - led research team has identified the likely genetic mechanism that causes
some patients with multiple sclerosis (MS) to progress more quickly than others to a debilitating stage of the disease.
Safety and immunological effects of mesenchymal stem cell transplantation in
patients with multiple sclerosis and amyotrophic lateral sclerosis.
Ekaterina Dobryakova, Ph D., a postdoctoral fellow in Kessler Foundation Neuropsychology and Neuroscience Research received a competitive research award from the New Jersey Neuropsychological Society to study whether motivation influences cognitive fatigue and the brain regions associated with it in
patients with multiple sclerosis (MS).
Robert Trossel, who also practised from Wimpole Street in central London, is accused by the General Medical Council of abusing his position as a doctor and offering treatment unjustified by the scientific evidence to
patients with multiple sclerosis and Hodgkin's disease.
In fact, it is estimated that 10 to 20 percent of
patients with multiple sclerosis, epilepsy chronic pain, and AIDS have admitted to smoking cannabis for therapeutic purposes.